Increased TSH levels may cause altered adipocyte physiology which causes the decreased release of insulin-sensitizing adipokines, such as adiponectin, that may lead to insulin resistance and associated comorbidities, such as the future development of type II diabetes mellitus (DM) [20]. The gene discussed is INS; the disease is Insulin resistance.